Jul 01, 2020 8:15am EDT OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees
Jun 09, 2020 8:00am EDT OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency
Jun 01, 2020 8:00am EDT FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
May 13, 2020 8:30am EDT OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services
May 08, 2020 9:00am EDT OPKO Health's BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents
May 06, 2020 4:05pm EDT OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results
Apr 29, 2020 1:35pm EDT OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies